These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 8115093)
41. Long-term follow-up of trigger point injections for abdominal wall pain. Nazareno J; Ponich T; Gregor J Can J Gastroenterol; 2005 Sep; 19(9):561-5. PubMed ID: 16151548 [TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H; Heinze A; Reichel G; Hefter H; Benecke R; Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [TBL] [Abstract][Full Text] [Related]
44. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Richards BA; Jensen Neurology; 2007 Mar; 68(12):963; author reply 963-4. PubMed ID: 17372141 [No Abstract] [Full Text] [Related]
45. A case of facial myofascial pain syndrome presenting as trigeminal neuralgia. Yoon SZ; Lee SI; Choi SU; Shin HW; Lee HW; Lim HJ; Chang SH Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):e29-31. PubMed ID: 19111486 [TBL] [Abstract][Full Text] [Related]
46. Sonography-guided trigger point injections in abdominal myofascial pain syndrome. Rhim HC; Cha JH; Cha J; Kim DH Medicine (Baltimore); 2020 Dec; 99(49):e23408. PubMed ID: 33285730 [TBL] [Abstract][Full Text] [Related]
47. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects? Hsieh RL; Lee WC Arch Phys Med Rehabil; 2008 Apr; 89(4):792-3; author reply 793. PubMed ID: 18374016 [No Abstract] [Full Text] [Related]
48. Why is aspirin a contraindication for trigger-point injections? Weiss BD Am Fam Physician; 2003 Jan; 67(1):32. PubMed ID: 12537164 [No Abstract] [Full Text] [Related]
49. Local anesthetic and steroidal prostatic injection for chronic pelvic pain syndrome: an effective last resort? Koo VS; O'brien A Clin J Pain; 2011 Feb; 27(2):166-8. PubMed ID: 20890181 [TBL] [Abstract][Full Text] [Related]
50. Electromyographic characterisation of abdominal wall trigger points developed after caesarean section and response to local anaesthesia: an observational study. Poli-Neto OB; Campos Martins Chamochumbi C; Toscano P; Pitanguy Julio M; Marques W; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA BJOG; 2018 Sep; 125(10):1313-1318. PubMed ID: 29485706 [TBL] [Abstract][Full Text] [Related]
51. Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain. Montenegro ML; Braz CA; Rosa-e-Silva JC; Candido-dos-Reis FJ; Nogueira AA; Poli-Neto OB BMC Anesthesiol; 2015 Dec; 15():175. PubMed ID: 26628263 [TBL] [Abstract][Full Text] [Related]
52. Therapeutic ultrasound versus injection of local anesthetic in the treatment of women with chronic pelvic pain secondary to abdominal myofascial syndrome: a randomized clinical trial. Baltazar MCDV; Russo JAO; De Lucca V; Mitidieri AMS; da Silva APM; Gurian MBF; Poli-Neto OB; Rosa-E-Silva JC BMC Womens Health; 2022 Aug; 22(1):325. PubMed ID: 35918696 [TBL] [Abstract][Full Text] [Related]
53. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. Anderson RU; Wise D; Sawyer T; Chan C J Urol; 2005 Jul; 174(1):155-60. PubMed ID: 15947608 [TBL] [Abstract][Full Text] [Related]
54. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems? Abbott J J Minim Invasive Gynecol; 2009; 16(2):130-5. PubMed ID: 19167273 [TBL] [Abstract][Full Text] [Related]
55. Interventional approaches to the management of myofascial pain syndrome. Criscuolo CM Curr Pain Headache Rep; 2001 Oct; 5(5):407-11. PubMed ID: 11560805 [TBL] [Abstract][Full Text] [Related]
56. Pretreatment anxiety and pain acceptance are associated with response to trigger point injection therapy for chronic myofascial pain. Healy GM; Finn DP; O'Gorman DA; Maharaj C; Raftery M; Ruane N; Mitchell C; Sarma K; Bohacek M; McGuire BE Pain Med; 2015 Oct; 16(10):1955-66. PubMed ID: 26309134 [TBL] [Abstract][Full Text] [Related]
57. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Scott NA; Guo B; Barton PM; Gerwin RD Pain Med; 2009 Jan; 10(1):54-69. PubMed ID: 18992040 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic pudendal nerve blocks using corticosteroids cure pelvic pain after failure of sacral neuromodulation. Antolak SJ; Antolak CM Pain Med; 2009 Jan; 10(1):186-9. PubMed ID: 19222779 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine. García-Leiva JM; Hidalgo J; Rico-Villademoros F; Moreno V; Calandre EP Pain Med; 2007; 8(1):65-70. PubMed ID: 17244105 [TBL] [Abstract][Full Text] [Related]
60. [Diclofenac compared with lidocaine in the treatment of myofascial pain by injections]. Frost A Ugeskr Laeger; 1986 Apr; 148(18):1077-8. PubMed ID: 3523902 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]